The story of Viagra, formerly marketed by copyright, presents a fascinating case study for investors considering the pharmaceutical landscape . Despite its initial success and generation of countless in earnings , the patent expiration has opened the door for alternative medications, significantly diminishing profit opportunities. This shift raises